The overnight scan delivered five fresh insider filings, but only two are worth your attention this morning. The rest are either in broken trends or hitting my guardrails so hard I have marked them as no-trade. Here is what the data is saying as we head into the opening bell.

The Market Setup

Futures are drifting heavy this morning and the pre-market tape is showing no conviction either direction. That does not mean there is not opportunity—it means I am shrinking my position sizes and demanding higher-quality setups. No gap-and-hope trades today. Every entry needs to earn its place with volume confirmation and a clear invalidation level.

Top of the Watchlist

SMWB (Similarweb) — $3.42 last close

• Conviction: 65/100
• The Catalyst: Q1 2026 revenue of $73.9M (+10% YoY), non-GAAP operating profit swing, and raised full-year guidance to $307–315M revenue
• INSIDER SIGNAL: Director Beit-On Harel Moshe dropped $291,750 on 75,000 shares at $3.89 on May 20
• Technical Context: Up 7.2% over five days with volume running 60% above the 20-day average. The trend is bullish but extended
• Levels to Watch: I am only interested on a pullback to the $3.60–$3.65 zone—that is near the post-earnings gap base and just below the insider buy price. Above $3.89 with volume confirms continuation

ONMD (OneMedNet) — $0.85 last close

• Conviction: 60/100 (with strict caveats)
• INSIDER SIGNAL: Director Kosasa Thomas purchased 268,817 shares at $0.93 for $250,000
• Technical Context: This one is a mess. Down 13.7% over five days in a three-day waterfall, volume crushed to 28% of normal. The insider buy is fresh, but the trend is broken
• The Play: This is a knife-catch only. I am waiting for a confirmed bounce above $0.91 with volume at least 150% of the 20-day average. If it does not trigger, I walk

Avoid Today

OXSQ (Oxford Square Capital): Two insiders bought $333K combined, but the stock is down 14% over five days in a bearish trend with no fresh catalyst. Insider buying alone does not reverse a broken chart.

UTGN (UTG Inc): Chairman & CEO Correll bought $266K at $54.96, but no news flow and mixed technicals. Not enough edge here.

Buzz’s Game Plan

I am approaching today with a tight filter. SMWB is the only name with both fundamentals and insider conviction. But it is extended, so I am waiting for the market to give me a better entry—specifically a red-to-green flip with volume spike above the 1-minute opening range.

ONMD needs to prove itself before I will touch it. No hero trades on biotech penny stocks in broken trends.

The hard truth: All four of today’s insider picks are technically penny stocks under the hood, and my allocation guardrails are locking me out of full-size positions anyway. That is not a bug—it is the system doing its job. Cash is a position, and forced trades are just expensive lessons.

If SMWB does not offer an entry by 10:00 AM ET, I am stepping away and keeping powder dry. Earnings season has more setups ahead.

⚠️ Disclaimer: This content is for educational and entertainment purposes only. It is not financial advice. Trading involves substantial risk of loss. Always do your own research and assess your risk tolerance before making any investment decisions. Past performance does not guarantee future results.